KAGA FEI Expands Wireless Module Lineup with Bluetooth 6 Support
KAGA FEI Co., Ltd., a global provider of leading short-distance wireless modules, today announced the expansion of its Bluetooth Low Energy module lineup with the introduction of the EC4L10BA1 and EC4L05BA1. These new modules offer varying memory capacities and complement the existing EC4L15BA1 model. All three modules feature built-in antenna and support Bluetooth 6.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250710721262/en/
EC4L10BA1, EC4L05BA1, EC4L15BA1
These modules leverage a chip with PSA*1 certification, enabling secure IoT development. Mass production is set to begin in January 2026, as we remain dedicated to expanding our product offerings based on market demand.
Product Features
1. Multiple Memory Options
Our modules offer diverse memory options: the EC4L15BA1 (1.5MB NVM/256KB RAM) for advanced use, the EC4L10BA1 (1.0MB NVM/192KB RAM), and the EC4L05BA1 (0.5MB NVM/96KB RAM). This range caters to applications from industrial IoT and healthcare to smart home devices and cost-sensitive, high-volume production.
2. Advanced Security Level
These modules simplify the development of IoT devices with high-security demands, thanks to a chip supporting PSA Level 3 certification—the highest level in IoT security standards. This significantly contributes to building a secure and safe network society, well-prepared against cyberattacks.
3. Multi-Protocol Support
The modules support Bluetooth Low Energy, Thread, and Matter standard*2. Furthermore, they can communicate using a proprietary 4Mbps mode.
4. Built-in Antenna and Pre-Certified
These modules integrate a built-in antenna, eliminating complex design needs. It's pre-certified with Radio Law MIC (Japan), FCC (USA), and ISED (Canada), significantly cutting development time and costs. Plus, it supports Bluetooth SIG qualification for the latest Bluetooth 6, enabling Channel Sounding for precise distance measurement.
Product Availability
Sample | : October 2025 |
Start of mass production | : January 2026 |
About Trademarks
The product names and other proper nouns mentioned herein are trademarks or registered trademarks of their respective companies.
*1. PSA: PSA (Platform Security Architecture) is a certification scheme led by Arm. Level 3 is the highest level of certification for protecting IoT devices from physical and software attacks.
*2. Matter standard: A smart home standard developed by the Connectivity Standards Alliance (CSA) to promote interoperability between smart home devices and IoT platforms from different manufacturers.
KAGA FEI website
https://www.kagafei.com/jp/eng/
Disclaimer
Product specifications, service content, etc. stated in the news release are as of the date of announcement and is subject to change without notice.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250710721262/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LevelBlue Completes Acquisition of Aon’s Cybersecurity and IP Litigation Consulting Groups1.8.2025 14:00:00 CEST | Press release
Strategic deal enhances LevelBlue's cybersecurity offerings, solidifying its position as the world’s largest leading independent, pure-play MSSP LevelBlue, a global leader in cloud-based, AI-driven managed security services, today announced the completion of its acquisition of Aon’s (NYSE: AON) Cybersecurity and Intellectual Property (IP) Litigation consulting groups, including the renowned cybersecurity firm, Stroz Friedberg, and Elysium Digital. With this completion the consulting group will operate as Stroz Friedberg, a LevelBlue company. This strategic acquisition adds elite cyber and high-tech IP litigation consulting expertise to the LevelBlue portfolio, which includes a globally recognized platform of approximately 300 technology professionals with deep relationships across Fortune 500 companies, 80 percent of the Am Law 100, and most of the UK’s top 20 law firms. As a result, LevelBlue will significantly fortify its incident response and advisory capabilities, while expanding i
SBC Medical to Announce Q2 2025 Financial Results and Hold Conference Call on August 13, 20251.8.2025 14:00:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, today announced that it will report its Q2 2025 financial results on Wednesday, August 13, 2025, before the U.S. market opens. The Company will hold a conference call on Wednesday, August 13, 2025 at 8:30 am Eastern Time (or Wednesday, August 13, 2025 at 9:30 pm Japan Time) to discuss the financial results and take questions live. Please register in advance of the conference using the link provided below. https://edge.media-server.com/mmc/p/ukc9sp9j It will automatically direct you to the registration page of “SBC Q2 2025 Financial Results Presentation.” Please follow the steps to enter your registration details, then click “Submit.” Upon registration, you will be able to access the dedicated Conference Call viewing site. In addition to viewing the conference call, this site provides access to information about the speakers as well a
San’an and Inari to Acquire 100% of Lumileds Holding B.V.’s Shares1.8.2025 11:05:00 CEST | Press release
San’an Optoelectronics and Inari Amertron Berhad today announced they have entered into a definitive agreement to acquire Lumileds Holding B.V. and its European and Asian subsidiaries (“Lumileds International”). “This transaction is the next step of our ongoing transformation. As the LED industry evolves and continues to mature, I am confident that Lumileds International will continue to be successful and accelerate its growth under the new ownership,” said Steve Barlow, CEO of Lumileds International. The transaction is expected to close by the first quarter of 2026, subject to customary closing conditions. About Lumileds International Lumileds International is a global leader in LED technology, innovation, and solutions for the automotive, display, illumination, mobile, and other markets where light sources are essential. Our approximately 3,300 employees operate in over 15 countries to partner with our customers to deliver solutions for lighting, safety, and well-being. About San’an
Rimini Street Announces Fiscal Second Quarter 2025 Financial and Operating Results31.7.2025 22:01:00 CEST | Press release
Second Quarter Financial Highlights Include: Gross margin of 60.4% compared to 59.1% in the prior year Adjusted Calculated Billings of $107.9 million compared to $103.8 million in the prior year Adjusted EBITDA of $13.0 million compared to $8.8 million in the prior year Revenue Retention Rate of 90% compared to 88% in the prior year Rimini Street, Inc., (the “Company”) (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the fiscal second quarter ended June 30, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731791846/en/ Rimini Street Announces Fiscal Second Quarter 2025 Financial and Operating Results Select Second Quarter 2025 Financial Results Revenue was $104.1 million for the 2025 second quarter, an increase of 1.0% compared to $103.1 million for the same
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development31.7.2025 20:56:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation (“VoxCell”), a leader in 3D bioprinting and human-like tissue modeling, are pleased to announce a strategic collaboration aimed at enhancing preclinical research and accelerating the path from discovery to clinical trials. This partnership combines Altasciences’ comprehensive early-phase drug development capabilities with VoxCell’s cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment. By integrating VoxCell’s high-resolution 3D bioprinted tissue platforms into Altasciences’ discovery and preclinical services, both companies aim to reduce R&D timelines and increase the success rate of investigational therapies. “We’re proud to partner with VoxCell BioInnovation to bring next-generation tissue modeling into the early stages of drug development,” said Steve Mason, Co-Chief Operating Officer at Altasciences. “This collaboration aligns with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom